Pheochromocytoma (DC 7918)
DC 7918 covers pheochromocytoma, a tumor of the adrenal medulla that overproduces catecholamines (adrenaline and noradrenaline), causing episodic or sustained hypertension, headaches, sweating, palpitations, and anxiety. About 10% of pheochromocytomas are malignant. DC 7918 itself has no rating ladder. Per the CFR Note, the rating is assigned as a malignant or benign endocrine neoplasm, as appropriate, under DC 7914 (malignant) or DC 7915 (benign). DC 7914 carries a 100% rating during active treatment with a mandatory six-month re-exam, then drops to residuals. DC 7915 is rated entirely on residual endocrine dysfunction (persistent hypertension, residual catecholamine excess, or other endocrine dysfunction after the tumor is treated).
Disclaimer: This tool is for informational purposes only and is not legal or medical advice. Always consult with your VSO representative or a qualified veterans benefits attorney for guidance on your specific claim.